Microfluidic occlusive thrombosis-on-a-chip can be used to monitor the effect of antithrombotic drugs
Myocardial infarction, commonly known as heart attack, causes a majority of cardiovascular disease (CVD) deaths which can be triggered by occlusion of the arteries. Finding new drugs to fight myocardial infractions requires accurate modelling of the process. In a recent article published in the lab...